Buscar
Tiziana Life Sciences Ltd
TLSAAñadir a la lista de seguimiento
1.030USD
+0.060+6.19%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
124.12MCap. mercado
PérdidaP/E TTM
Más Datos de Tiziana Life Sciences Ltd Compañía
Tiziana Life Sciences Ltd. is a United Kingdom-based clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The Company’s clinical pipeline includes drug assets for secondary progressive multiple sclerosis, Alzheimer’s, and ALS. Its lead immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer’s and other CNS indications. Its Anti-IL-6R mAb (TZLS-501), a fully human mAb, binds to both membrane-bound and soluble forms of IL-6R, an inflammatory cytokine driving chronic inflammation associated with autoimmune and cancer, reducing circulating levels of the IL-6 cytokine. Its oncology product candidate, Milciclib, is a combination therapy for the treatment of refractory solid tumors (being cancers which are non-responsive or become resistant to treatment), especially non-small cell lung cancer (NSCLC).
Información de Tiziana Life Sciences Ltd
Símbolo de cotizaciónTLSA
Nombre de la empresaTiziana Life Sciences Ltd
Fecha de salida a bolsaNov 20, 2018
Director ejecutivoElrifi (Ivor)
Número de empleados8
Tipo de seguridadOrdinary Share
Fin del año fiscalNov 20
Dirección3rd Floor, 11-12 St. James's Square
CiudadLONDON
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited Kingdom
Código postalSW1Y 4LB
Teléfono442074952379
Sitio Webhttps://www.tizianalifesciences.com/
Símbolo de cotizaciónTLSA
Fecha de salida a bolsaNov 20, 2018
Director ejecutivoElrifi (Ivor)
Ejecutivos de Tiziana Life Sciences Ltd
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ivor Elrifi
Mr. Ivor Elrifi
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.69M
--
Mr. Willy Jules Simon
Mr. Willy Jules Simon
Non-Executive Independent Director
Non-Executive Independent Director
8.25K
--
Mr. Gabriele Marco Antonio Cerrone
Mr. Gabriele Marco Antonio Cerrone
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. John P. Brancaccio, CPA
Mr. John P. Brancaccio, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Keeren Shah
Ms. Keeren Shah
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. William A. Clementi, Pharm.D.
Dr. William A. Clementi, Pharm.D.
Chief Development Officer
Chief Development Officer
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Ivor Elrifi
Mr. Ivor Elrifi
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
2.69M
--
Mr. Willy Jules Simon
Mr. Willy Jules Simon
Non-Executive Independent Director
Non-Executive Independent Director
8.25K
--
Mr. Gabriele Marco Antonio Cerrone
Mr. Gabriele Marco Antonio Cerrone
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Mr. John P. Brancaccio, CPA
Mr. John P. Brancaccio, CPA
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Keeren Shah
Ms. Keeren Shah
Chief Financial Officer, Chief Operating Officer
Chief Financial Officer, Chief Operating Officer
--
--
Dr. William A. Clementi, Pharm.D.
Dr. William A. Clementi, Pharm.D.
Chief Development Officer
Chief Development Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Tiziana Life Sciences Ltd?
Los cinco principales accionistas de Tiziana Life Sciences Ltd son: Mr. Ivor Elrifi
¿Cuántas instituciones poseen acciones de Tiziana Life Sciences Ltd (TLSA)?
A fecha de 2026Q1, 75 instituciones poseen acciones de Tiziana Life Sciences Ltd, con un valor de mercado combinado de aproximadamente 3.95M, lo que representa el 3.10% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -2438604.00.